This COVID-19 roundup includes coverage on a revised version of the FDA’s emergency use authorization of tixagevimab/cilgavimab, a new study that compared the efficacy of vaccines and boosters in mortality...
The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
This COVID-19 roundup includes coverage on vaccine safety for older adults, the efficacy of fluvoxamine on COVID-19 symptoms, the use of convalescent plasma transfusion in immunocompromised patients, and...
Researchers examined the efficacy of post-exposure prophylaxis for the prevention of sexually transmitted infections among certain patient populations living with HIV or on HIV pre-exposure prophylaxis. ...
Researchers examined the effectiveness of the monoclonal antibody, nirsevimab, in protecting infants from the respiratory syncytial virus (RSV) and RSV lower respiratory tract infection.
This COVID-19 roundup includes coverage on vaccine safety for pediatric patients with MIS-C, molnupiravir not reducing hospital admissions or deaths, the evolution of COVID-19 standard of care measures and...
The Department of Health and Human Services recommends testing for sexually transmitted infections prior to beginning PrEP for those at-risk of HIV. Researchers examined the prevalence of these infections...
In this COVID-19 roundup, we discuss updates to the CDC’s mask recommendations, ways to predict COVID-19 severity, and how long a person might remain infectious.
To conduct their study, the researchers used data from COVID-19 cases reported to the US-based National COVID Cohort Collaborative to evaluate COVID-19 disease severity, hospitalizations, and mortality...
